ATE186836T1 - Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen - Google Patents

Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen

Info

Publication number
ATE186836T1
ATE186836T1 AT95905416T AT95905416T ATE186836T1 AT E186836 T1 ATE186836 T1 AT E186836T1 AT 95905416 T AT95905416 T AT 95905416T AT 95905416 T AT95905416 T AT 95905416T AT E186836 T1 ATE186836 T1 AT E186836T1
Authority
AT
Austria
Prior art keywords
glucitol
dideoxy
imino
hepatitis
infections
Prior art date
Application number
AT95905416T
Other languages
English (en)
Inventor
Timothy M Block
Baruch S Blumberg
Raymond A Dwek
Original Assignee
Searle & Co
Monsanto Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co, Monsanto Co filed Critical Searle & Co
Application granted granted Critical
Publication of ATE186836T1 publication Critical patent/ATE186836T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT95905416T 1994-01-13 1994-12-23 Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen ATE186836T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US18151994A 1994-01-13 1994-01-13

Publications (1)

Publication Number Publication Date
ATE186836T1 true ATE186836T1 (de) 1999-12-15

Family

ID=22664619

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95905416T ATE186836T1 (de) 1994-01-13 1994-12-23 Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen

Country Status (14)

Country Link
US (1) US6037351A (de)
EP (1) EP0739205B1 (de)
JP (1) JP3628021B2 (de)
KR (1) KR100348657B1 (de)
CN (1) CN1074921C (de)
AT (1) ATE186836T1 (de)
AU (1) AU1403795A (de)
CA (1) CA2181033C (de)
DE (1) DE69421828T2 (de)
DK (1) DK0739205T3 (de)
ES (1) ES2140652T3 (de)
GR (1) GR3032527T3 (de)
PT (1) PT739205E (de)
WO (1) WO1995019172A1 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030100532A1 (en) * 1997-02-14 2003-05-29 Gary S. Jacob Use of n-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy for treating hepatitis virus infections
PT1030839E (pt) 1997-11-10 2004-05-31 Searle & Co Utilizacao de iminoacucares para tratar a resistencia a multifarmacos
US6689759B1 (en) 1998-02-12 2004-02-10 G. D. Searle & Co. Methods of Treating hepatitis virus infections with N-substituted-1,5-dideoxy-1,5-imino-d-glucitol compounds in combination therapy
DE69932154T2 (de) * 1998-02-12 2007-05-31 G.D. Searle Llc, Chicago Verwendung von n-substituirten-1,5-dideoxy-1,5-imino-d-glucitolen zur behandlung von hepatitis infektionen
EP1714676A3 (de) * 1998-02-12 2006-11-15 G.D. Searle LLC. N-substituierte 1,5-dideoxy-1,5-imino-D-glucitol Verbindungen für die Therapie von Hepatitis Virus Infektionen
US6274597B1 (en) 1998-06-01 2001-08-14 Mount Sinai School Of Medicine Of New York University Method of enhancing lysosomal α-Galactosidase A
EP1658846B1 (de) * 1999-02-12 2008-07-30 United Therapeutics Corporation N-(8,8,8-Trifluorooctyl)-1,5-dideoxy-1,5-imino-D-glucitol zur Behandlung von Hepatitis-Virus-Infektionen
ATE402701T1 (de) * 1999-02-12 2008-08-15 United Therapeutics Corp N-(8,8,8-trifluorooctyl)-1,5-dideoxy-1,5-imino- - glucitol zur behandlung von hepatitis-virus- infektionen
JP2003505501A (ja) 1999-02-12 2003-02-12 ジー・ディー・サール・アンド・カンパニー 肝炎ウィルス感染の処置のためのグルカミン化合物
ES2302697T3 (es) 1999-08-10 2008-08-01 The Chancellor, Masters And Scholars Of The University Of Oxford Compuestos n-alquilicos de cadena larga y derivados oxa de los mismos y uso como composiciones antivirales.
JP2003522791A (ja) * 2000-02-14 2003-07-29 ファルマシア コーポレイション 肝炎ウイルス感染症治療用ｎ‐置換‐１，５‐ジデオキシ‐１，５‐イミノ‐ｄ‐グルシトール化合物の使用
US20060052414A1 (en) * 2004-08-13 2006-03-09 Migenix, Inc. Compositions and methods for treating or preventing Hepadnaviridae infection
CN104876855A (zh) 2006-05-24 2015-09-02 联合治疗公司 脱氧吉瑞霉素和d-阿拉伯胶素醇类似物及使用方法
KR20090057035A (ko) * 2006-08-21 2009-06-03 유나이티드 세러퓨틱스 코오포레이션 바이러스 감염의 치료를 위한 병용 요법
US8097728B2 (en) 2007-04-30 2012-01-17 Philadelphia Health & Education Corporation Iminosugar compounds with antiflavirus activity
JP2013233113A (ja) * 2012-05-09 2013-11-21 Osaka Univ 物理的負荷への耐性が向上した細胞の製造方法
RU2743694C1 (ru) * 2019-12-04 2021-02-24 Общество с ограниченной ответственностью "29 февраля" Миглустат N-бутил-1,5-дидезокси-1,5-имино-D-глюцит

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1555654A (en) * 1977-06-25 1979-11-14 Exxon Research Engineering Co Agricultural burner apparatus
US4849430A (en) * 1988-03-09 1989-07-18 Monsanto Company Method of inhibiting virus
US4957926A (en) * 1988-12-22 1990-09-18 Monsanto Company Method of treating herpesviruses
US5030638A (en) * 1990-02-26 1991-07-09 G. D. Searle & Co. Method of antiviral enhancement

Also Published As

Publication number Publication date
ES2140652T3 (es) 2000-03-01
CN1074921C (zh) 2001-11-21
PT739205E (pt) 2000-04-28
AU1403795A (en) 1995-08-01
DK0739205T3 (da) 2000-05-01
KR100348657B1 (ko) 2003-08-02
WO1995019172A1 (en) 1995-07-20
EP0739205B1 (de) 1999-11-24
JP3628021B2 (ja) 2005-03-09
JPH09508111A (ja) 1997-08-19
GR3032527T3 (en) 2000-05-31
US6037351A (en) 2000-03-14
EP0739205A1 (de) 1996-10-30
CN1149253A (zh) 1997-05-07
DE69421828T2 (de) 2000-04-20
CA2181033A1 (en) 1995-07-20
CA2181033C (en) 2007-09-04
DE69421828D1 (de) 1999-12-30

Similar Documents

Publication Publication Date Title
ATE186836T1 (de) Verwendung von 1,5-dideoxy-1,5-imino-d-glucitol n-alkylderivaten zur behandlung von hepatitis b infektionen
NO20073151L (no) Fremgangsmater og sammensetninger for a behandle hepatitt C virus
DE60105424D1 (de) Methoden zur behandlung von delta hepatitis virus infektionen mit beta-l-2' deoxy-nucleosiden
MD1507G2 (ro) Inhibitori, compoziţie farmaceutică pe baza lor şi procedeu de inhibare a HIV proteazei
NZ326555A (en) Inhibitors of interleukin-1beta converting enzyme (ICE)
DE69535758D1 (de) Lipid-analoge zur behandlung von viralen infektionen
HUT61296A (en) Process for producing substituted diaromatic compounds against aids and pharmaceutical compositions comprising same
AU2001259068A1 (en) 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections
ES2102154T3 (es) Inhibicion de trombina.
ATE189601T1 (de) Verwendung von raloxifen und dessen analogen zur herstellung eines medikaments zur behandlung viraler erkrankungen
FR2741619B1 (fr) Nouveaux derives de 2,3,5-trimethyl-4-hydroxy-anilides, leur preparation et leur application en therapeutique
DE69019533D1 (de) Behandlung von hiv-infizierungen und nützliche verbindungen dafür.
DE68923151D1 (de) Verwendung von Trifluormethylphenyl-Tetrahydropyridinen zur Herstellung von Arzneimitteln zur Behandlung anxio-depressiver Erkrankungen.
NZ217398A (en) Angiotensin-converting enzyme(ace)inhibitor and pharmaceutical composition
DE69612510D1 (de) Verwendung von 1-(2-naphtylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridin zur herstellung eines medikaments zur behandlung der amyotrophen lateralsklerode
ATE339211T1 (de) L-fmau zur behandlung von hepatitis-delta-virus- infizierung
DE69232417D1 (de) Michellamine zur verwendung als antivirale wirkstoffe, zusammensetzung und behandlungsverfahren
BR9610175A (pt) Composto processo de preparação do composto composição farmacêutica e utilização do composto
NZ335493A (en) Substituted 4-(6-fluoro-(1h)-indol-3-yl)-1,2,3,6-tetrahydropyridine for the treatment of CNS-disorders
EP0769945A4 (de) Verfahren zur knochenheilung und bruchreparatur
SE8302452D0 (sv) Method for treatment of senile dementia
FR2729665B1 (fr) Nouveaux derives de glycylanilides, leur preparation et leur application en therapeutique
DK0853619T3 (da) Disubstituerede piperidinderivater
ATE269704T1 (de) Pyrroloazepinderivate enthaltende arzneimittel zur behandlung von claudicatio intermittens

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification